Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Okapi Resources Ltd. ( (AU:GUE) ).
Ubaryon has advanced its strategic planning to secure long-term funding and is making significant progress in developing its 100% owned Uranium Enrichment Technology. The company is actively pursuing a strategic partner to expedite commercial outcomes and address the recent restrictions on enriched uranium exports from Russia to the U.S. This initiative is critical as it could provide significant advantages in one of the most regulated industries. Additionally, Ubaryon is expanding its lab facilities to enhance its technical capabilities and is exploring the potential of its technology in separating stable isotopes for medical and other applications.
More about Okapi Resources Ltd.
Ubaryon is a private Australian company focused on the development and commercialization of a unique uranium enrichment technology. This technology is based on the chemical separation of naturally occurring uranium isotopes and offers a more efficient enrichment process without the need for conversion and deconversion, enhancing flexibility in the nuclear fuel supply chain.
YTD Price Performance: 26.67%
Average Trading Volume: 485,824
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$22.99M
See more data about GUE stock on TipRanks’ Stock Analysis page.
